Lucid Diagnostics Inc. Increase (Decrease) in Prepaid Expenses, Other
Lucid Diagnostics Inc. (LUCD) reported Increase (Decrease) in Prepaid Expenses, Other of $1.23 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2025-11-12
- Lucid Diagnostics Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was $283.00K.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-06-30 was $757.00K.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2025-03-31 was $185.00K.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2024-12-31 was -$94.00K.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expenses, other for fiscal 2024 was -$1.16M, a 199.91% decline from fiscal 2023.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expenses, other for fiscal 2023 was $1.16M.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expenses, other for fiscal 2022 was -$1.16M, a 155.70% decline from fiscal 2021.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expenses, other for fiscal 2021 was $2.09M.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|
| 2025-09-30 | $283.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.04M derived: sum of 2 quarters · filed 2025-11-12 | $1.23M 10-Q · filed 2025-11-12 | $1.13M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | $757.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $942.00K 10-Q · filed 2025-08-12 | $848.00K derived: sum of 3 quarters · filed 2025-08-12 | $408.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | $185.00K 10-Q · filed 2025-05-13 | $91.00K derived: sum of 2 quarters · filed 2025-05-13 | -$349.00K derived: sum of 3 quarters · filed 2025-11-12 | -$629.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | -$94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$534.00K derived: sum of 2 quarters · filed 2025-11-12 | -$814.00K derived: sum of 3 quarters · filed 2025-11-12 | -$1.16M 10-K · filed 2025-03-24 |
| 2024-09-30 | -$440.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$720.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.06M 10-Q · filed 2025-11-12 | -$1.17M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$280.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$625.00K 10-Q · filed 2025-08-12 | -$727.00K derived: sum of 3 quarters · filed 2025-08-12 | -$585.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$345.00K 10-Q · filed 2025-05-13 | -$447.00K derived: sum of 2 quarters · filed 2025-05-13 | -$305.00K derived: sum of 3 quarters · filed 2025-05-13 | $540.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $40.00K derived: sum of 2 quarters · filed 2025-03-24 | $885.00K derived: sum of 3 quarters · filed 2025-03-24 | $1.16M 10-K · filed 2025-03-24 |
| 2023-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $987.00K derived: sum of 2 quarters · filed 2024-11-12 | $1.26M 10-Q · filed 2024-11-12 | $270.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $845.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $1.12M 10-Q · filed 2024-08-12 | $128.00K derived: sum of 3 quarters · filed 2024-08-12 | -$791.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $275.00K 10-Q · filed 2024-05-13 | -$717.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.64M derived: sum of 3 quarters · filed 2024-05-13 | -$720.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$992.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$1.91M derived: sum of 2 quarters · filed 2024-03-25 | -$995.00K derived: sum of 3 quarters · filed 2024-03-25 | -$1.16M 10-K · filed 2024-03-25 |
| 2022-09-30 | -$919.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$3.00K derived: sum of 2 quarters · filed 2023-11-13 | -$171.00K 10-Q · filed 2023-11-13 | $963.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $916.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $748.00K 10-Q · filed 2023-08-14 | $1.88M derived: sum of 3 quarters · filed 2023-08-14 | $2.32M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$168.00K 10-Q · filed 2023-05-15 | $966.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.41M derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.57M derived: sum of 2 quarters · filed 2023-03-14 | $2.09M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $439.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $954.00K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $515.00K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |